Showing results (31-40 of 81) with videos related to
Sort By:
Pageof 9
Current Oncology Reports|May 16, 2025
State-of-the-art in Metastatic Uveal Melanoma Treatment: A 2025 Update : How to treat Metastatic Uveal Melanoma in 2025Dimitrios C Ziogas, Dimitra Foteinou, Charalampos Theocharopoulos, et al.Annals of Translational Medicine|June 5, 2018
Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?Georgios Tsironis, Dimitrios C Ziogas, Anastasios Kyriazoglou, et al.Journal for Immunotherapy of Cancer|November 4, 2020
When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case reportDimitrios C Ziogas, Aikaterini Gkoufa, Evangelos Cholongitas, et al.Critical Reviews in Oncology/Hematology|March 30, 2022
Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 updateAristeidis E Boukouris, Maria Theochari, Dimitra Stefanou, et al.Cancer Treatment Reviews|August 2, 2024
Antibody-drug conjugates for hepato-pancreato-biliary malignancies: "Magic bullets" to the rescue?Charalampos Theocharopoulos, Ioannis A Ziogas, Charalampos-Christos Douligeris, et al.Cancers|June 22, 2023
Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma TreatmentDimitrios C Ziogas, Charalampos Theocharopoulos, Panagiotis-Petros Lialios, et al.Frontiers in Oncology|November 1, 2021
Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic ReviewDimitrios C Ziogas, Dimitrios Mandellos, Charalampos Theocharopoulos, et al.Frontiers in Oncology|October 22, 2024
Immunotherapy after progression to double immunotherapy: pembrolizumab and lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibitionGeorgios Lyrarakis, Michael Liontos, Amalia Anastasopoulou, et al.Plos One|February 28, 2015
Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patientsAristea Papageorgiou, Dimitrios C Ziogas, Clio P Mavragani, et al.The Oncologist|April 10, 2020
Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated MelanomaDimitrios C Ziogas, Panagiotis Diamantopoulos, Olga Benopoulou, et al.Pageof 9